Corbus Pharmaceuticals Holdings Inc (CRBP)

Is Corbus Pharmaceuticals Holdings Inc (CRBP) A Buy Now?

According to our latest analysis, CRBP could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CRBP, as trading bearish markets can be challenging and may result in losses.

1. RSI (Relative Strength Index): The RSI(14) value of 34.29 indicates that CRBP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
2. STOCH (Stochastic Oscillator): The STOCH value of 49.99 indicates that CRBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 73.73 indicates that CRBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
4. ADX (Average Directional Index): The ADX value of 53.74 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
5. CCI (Commodity Channel Index): A CCI(14) value of -62.00 indicates that CRBP is still oversold but not to an extreme extent.

Long-term CRBP price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Corbus Pharmaceuticals Holdings Inc financial reports and earnings history, Corbus Pharmaceuticals Holdings Inc (CRBP) stock could reach $49.32 by 2030, $44.96 by 2040 and $102.98 by 2050. See the projected annual prices until 2050 of the Corbus Pharmaceuticals Holdings Inc stock below:

• Corbus Pharmaceuticals Holdings Inc (CRBP) is expected to reach an average price of $7.39 in 2035, with a high prediction of $36.87 and a low estimate of $1.27. This indicates an +118.06% change from the last recorded price of $3.39.
• Corbus Pharmaceuticals Holdings Inc (CRBP) stock is projected to chart a bullish course in 2040, with an average price target of $2.68, representing an -21.03% change from its current level. The forecast ranges from a conservative $4.85 to a sky-high $44.96.
• Our analysts predict Corbus Pharmaceuticals Holdings Inc (CRBP) to change +1,643% by 2045, soaring from $59.46 to an average price of $59.07, potentially reaching $76.60. While $59.46 is the low estimate, the potential upside is significant.
• Corbus Pharmaceuticals Holdings Inc (CRBP) stock is expected to climb by 2050, reaching an average of $91.42, a +2,597% change from its current level. However, a wide range of estimates exists, with high and low targets of $102.98 and $91.30, respectively, highlighting the market's uncertainty.

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Year by Year Forecast